scholarly journals Implantation of cardiac resynchronisation therapy with defibrillation more cost effective than implantable cardioverter defibrillator therapy alone in patients with left ventricular dysfunction

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. P3205-P3205
Author(s):  
F. Umar ◽  
R. J. Taylor ◽  
A. Vakharia ◽  
H. Marshall ◽  
F. Leyva
Keyword(s):  
Implantable Cardioverter Defibrillator ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Cost Effective ◽  
Cardiac Resynchronisation Therapy ◽  
Left Ventricular ◽  
Implantable Cardioverter Defibrillator Therapy ◽  
Cardioverter Defibrillator ◽  
Cardiac Resynchronisation ◽  
Resynchronisation Therapy

scholarly journals Use of Cardiac Resynchronisation Therapy – Change of Clinical Settings

2014 ◽  
Vol 3 (1) ◽  
pp. 20-24 ◽  
Author(s):  
Khang-Li Looi ◽  
Anthony SL Tang ◽  
Sharad Agarwal
Keyword(s):  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Cardiac Resynchronisation Therapy ◽  
Left Ventricular ◽  
Left Ventricular Ejection ◽  
Severe Left Ventricular Dysfunction ◽  
Surface Ecg ◽  
Cardiac Resynchronisation ◽  
Resynchronisation Therapy ◽  
Qrs Duration

Current guidelines recommend cardiac resynchronisation therapy (CRT) for patients with severe left ventricular dysfunction (left ventricular ejection fraction [LVEF] ≤35 %), QRS duration of ≥120–150 ms (Class IA and IB indications) on surface electrocardiogram (ECG) and New York Heart Association (NYHA) class III or IV heart failure (HF) symptoms. Ongoing studies aim to expand the use of CRT in patients with asymptomatic or minimal symptoms left ventricular dysfunction. There have been studies that have shown benefit of CRT extended to this group of patients. There have also been different implications of the role of CRT in patients with atrial fibrillation (AF), patients with narrow QRS duration or with right bundle branch block (RBBB) on surface ECG, as well as patients with end-stage renal failure on dialysis therapy. This article aims to review the current body of evidence of expanding use of CRT in these populations.

Refining the Indications of Implantable Cardioverter Defibrillator in Patients with Left Ventricular Dysfunction

2012 ◽  
Vol 7 (3) ◽  
pp. 197-203 ◽  
Author(s):  
Esteban Gonzalez-Torrecilla ◽  
Angel Arenal ◽  
Felipe Atienza ◽  
Tomas Datino ◽  
Gabriel Eidelman ◽  
...  
Keyword(s):  
Implantable Cardioverter Defibrillator ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
Cardioverter Defibrillator
Sign in / Sign up

Export Citation Format

Share Document